ALVO
Price
$5.81
Change
-$0.03 (-0.51%)
Updated
Sep 23 closing price
Capitalization
2.08B
48 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$13.84
Change
-$0.47 (-3.28%)
Updated
Sep 23 closing price
Capitalization
1.99B
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALVO vs PRGO

ALVO vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
ALVO vs. PRGO commentary
Sep 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Buy and PRGO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ALVO vs PRGO: Fundamental Ratings
ALVO
PRGO
OUTLOOK RATING
1..100
4385
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3639
P/E GROWTH RATING
1..100
132
SEASONALITY SCORE
1..100
4150

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (53) in the Pharmaceuticals Other industry is in the same range as ALVO (55) in the null industry. This means that PRGO’s stock grew similarly to ALVO’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ALVO (100) in the null industry. This means that PRGO’s stock grew similarly to ALVO’s over the last 12 months.

PRGO's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as ALVO (100) in the null industry. This means that PRGO’s stock grew similarly to ALVO’s over the last 12 months.

ALVO's Price Growth Rating (36) in the null industry is in the same range as PRGO (39) in the Pharmaceuticals Other industry. This means that ALVO’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is in the same range as ALVO (13) in the null industry. This means that PRGO’s stock grew similarly to ALVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALVOPRGO
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
63%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
61%
Advances
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 3 days ago
63%
Declines
ODDS (%)
Bearish Trend 10 days ago
78%
Bearish Trend 8 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
58%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
58%
COMPARISON
Comparison
Sep 24, 2026
Stock price -- (ALVO: $5.81 vs. PRGO: $13.84)
Brand notoriety: ALVO and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 70% vs. PRGO: 53%
Market capitalization -- ALVO: $2.08B vs. PRGO: $1.99B
ALVO [@Pharmaceuticals: Generic] is valued at $2.08B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $1.99B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $66.17B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALVO and PRGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 5 TA indicator(s) are bullish while PRGO’s TA Score has 5 bullish TA indicator(s).

  • ALVO’s TA Score: 5 bullish, 4 bearish.
  • PRGO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than PRGO.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +13.92% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +2.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +3.76%. For the same industry, the average monthly price growth was -5.19%, and the average quarterly price growth was +43.31%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 11, 2026.

PRGO is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+3.76% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ALVO
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
THD74.521.03
+1.40%
iShares MSCI Thailand ETF (THD)
SCCR24.77N/A
N/A
Schwab Core Bond ETF (SCCR)
JETU24.98N/A
-0.02%
MAX Airlines 3X Leveraged ETNs (JETU)
STXT19.40-0.04
-0.18%
Strive Total Return Bond ETF (STXT)
NITE39.61-0.18
-0.46%
The Nightview Fund ETF (NITE)

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and CRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-0.68%
CRON - ALVO
24%
Poorly correlated
+3.00%
EBS - ALVO
23%
Poorly correlated
+3.21%
PAHC - ALVO
22%
Poorly correlated
+1.36%
ACB - ALVO
22%
Poorly correlated
+5.96%
LFCR - ALVO
21%
Poorly correlated
+0.33%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-3.28%
SUPN - PRGO
49%
Loosely correlated
-0.82%
ELAN - PRGO
37%
Loosely correlated
-1.57%
EVO - PRGO
36%
Loosely correlated
-2.53%
ALVO - PRGO
34%
Loosely correlated
-0.51%
PBH - PRGO
33%
Poorly correlated
-3.79%
More